# Inmune Bio, Inc.: insider transactions

INMB · Nasdaq · CIK 1711754 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inmb.md) · [Financials](/companies/inmb/financials.md) · [Filings](/companies/inmb/filings.md) · [Insiders](/companies/inmb/insiders.md)

## All transactions: 4

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2021-09-03 | [Xencor Inc](/insiders/1326732.md) | 10% owner | Option exercise (M) | 108,000 | $7.80 | $842.4k | [Form 4](/filings/0001415889-21-004281.md) |
| 2021-06-10 | [Xencor Inc](/insiders/1326732.md) | 10% owner | Other (J) | 192,532 | $17.14 | $3.3m | [Form 4](/filings/0001415889-21-002991.md) |
| 2021-06-10 | [Xencor Inc](/insiders/1326732.md) | 10% owner | Other (J) | 192,533 | $17.14 | $3.3m | [Form 4/A](/filings/0001415889-21-004279.md) |
| 2021-06-10 | [Xencor Inc](/insiders/1326732.md) | 10% owner | Other (J) | 192,533 | $17.14 | $3.3m | [Form 4/A](/filings/0001415889-21-004280.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 29, 2026, 07:41 ET. No prices; not investment advice.